Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Elif Gülsüm Ümit"'
Autor:
Elif Gülsüm Ümit, Ahmet Muzaffer Demir, Muhlis Cem Ar, Mesut Ayer, Meltem Aylı, Volkan Karakuş, Emin Kaya, Fahir Özkalemkaş, Nilgün Sayınalp, Mehmet Sönmez, Fahri Şahin, Selami Koçak Toprak, Tayfur Toptaş, İrfan Yavaşoğlu, Ümran Çalış
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 3, Pp 141-145 (2024)
Objective: Primary immune thrombocytopenia (ITP) is an acquired disorder of platelets with a complex and unclear mechanism of increased immune destruction or impaired production of platelets. While the management of ITP is evolving, there is still a
Externí odkaz:
https://doaj.org/article/054d63ab37a14969ae51686eef5b3e9e
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 3, Pp 175-181 (2024)
The Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) is a surrogate marker for symptom evaluation in chronic myeloproliferative neoplasms (MPNs). However, insufficient data are available regarding the relationship amon
Externí odkaz:
https://doaj.org/article/282d7082609341b19384f08608a1e0b0
Autor:
Ahmet Muzaffer Demir, Elif Gülsüm Ümit, Muhlis Cem Ar, Mesut Ayer, Meltem Aylı, Volkan Karakuş, Emin Kaya, Fahir Özkalemkaş, Nilgün Sayınalp, Mehmet Sönmez, Fahri Şahin, Selami Koçak Toprak, Tayfur Toptaş, İrfan Yavaşoğlu, Ümran Çalış
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 2, Pp 97-104 (2024)
Objective: Primary immune thrombocytopenia (pITP) is an acquired autoimmune disorder related to the increased destruction and/or impaired production of platelets. Its diagnosis and management are challenging and require expertise and the interpretati
Externí odkaz:
https://doaj.org/article/fb37fc3017d44f9e90832b4fba39d603
Autor:
Eren Gündüz, Hakkı Onur Kırkızlar, Elif Gülsüm Ümit, Sedanur Karaman Gülsaran, Vildan Özkocaman, Fahir Özkalemkaş, Ömer Candar, Tugrul Elverdi, Selin Küçükyurt, Semra Paydaş, Özcan Çeneli, Sema Karakuş, Senem Maral, Ömer Ekinci, Yıldız İpek, Cem Kis, Zeynep Tuğba Güven, Aydan Akdeniz, Tiraje Celkan, Ayşe Hilal Eroğlu Küçükdiler, Gülsüm Akgün Çağlıyan, Ceyda Özçelik Şengöz, Ayşe Karataş, Tuba Bulduk, Alper Özcan, Fatma Burcu Belen Apak, Aylin Canbolat, İbrahim Kartal, Hale Ören, Ersin Töret, Gül Nihal Özdemir, Şule Mine Bakanay Öztürk
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 2, Pp 130-135 (2022)
Objective: Castleman disease (CD) is a rare disease also known as angiofollicular lymph node hyperplasia. The two main histological subtypes are the hyaline vascular and plasma cell variants. It is further classified as unicentric CD (UCD) or multice
Externí odkaz:
https://doaj.org/article/90602ce9f9bf437588736f9a063da92f
Autor:
Anıl Tombak, Funda Pepedil Tanrıkulu, Salih Sertaç Durusoy, Hüseyin Derya Dinçyürek, Emin Kaya, Elif Gülsüm Ümit, İrfan Yavaşoğlu, Özgür Mehtap, Burak Deveci, Mehmet Ali Özcan, Hatice Terzi, Müfide Okay, Nilgün Sayınalp, Mehmet Yılmaz, Vahap Okan, Alperen Kızıklı, Ömer Özcan, Güven Çetin, Sinan Demircioğlu, İsmet Aydoğdu, Güray Saydam, Eren Arslan Davulcu, Gül İlhan, Mehmet Ali Uçar, Gülsüm Özet, Seval Akpınar, Burhan Turgut, İlhami Berber, Erdal Kurtoğlu, Mehmet Sönmez, Derya Selim Batur, Rahşan Yıldırım, Vildan Özkocaman, Ahmet Kürşad Güneş, Birsen Sahip, Şehmus Ertop, Olga Meltem Akay, Abdülkadir Baştürk, Mehmet Hilmi Doğu, Aydan Akdeniz, Ali Ünal, Ahmet Seyhanlı, Emel Gürkan, Demet Çekdemir, Burhan Ferhanoğlu
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 4, Pp 273-285 (2021)
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +- standard deviat
Externí odkaz:
https://doaj.org/article/506b9a34c2d64dd5beb096f766347808
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Externí odkaz:
https://doaj.org/article/63ea328533ef473098907a3a639de4c7
Publikováno v:
Turkish Journal of Hematology, Vol 34, Iss 1, Pp 89-92 (2017)
Objective: Vancomycin-resistant enterococci (VRE) are common pathogens of hospital-acquired infection. Long hospitalization periods, use of broadspectrum antibiotics, and immunosuppression are major risks for VRE colonization. We aimed to evaluate pa
Externí odkaz:
https://doaj.org/article/33d1dae1c80b4caa98216fc11cdce0ce
Publikováno v:
Balkan Medical Journal, Vol 35, Iss 5, Pp 398-399 (2018)
Background:Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, and rheumatoid arthritis. Unlike other monoclonal antibodies such as infliximab and adalimumab, certolizumab does not contain an Fc fractio
Externí odkaz:
https://doaj.org/article/dcc631e36f3e4b5689a07108899587e5
Autor:
Elif Gülsüm Ümit
Publikováno v:
Balkan Medical Journal, Vol 33, Iss 6, Pp 710-711 (2016)
Externí odkaz:
https://doaj.org/article/f26c24406b89424b867ab15ba3da64aa
Autor:
Aydan Akdeniz, Ayşegül Ünüvar, Muhlis Cem Ar, Esra Pekpak, Arzu Akyay, Özgür Mehtap, Fatma Keklik Karadağ, Can Acıpayam, Ali Doğan, Ömer Ekinci, Sultan Aydın Köker, Canan Albayrak, Ufuk Demirci, Tekin Güney, Meltem Kurt, Serap Karaman, Özge Şahin Kimyon, Sinan Albayrak, Yurday Öncül, Serkan Ünal, Fahri Şahin, Rumeysa Tuna, Bulent Zulfikar, Burcu Belen Apak, Elif Gülsüm Ümit, Ahmet Muzaffer Demir
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 82:28-36
Introduction: Inherited factor VII (FVII) deficiency (FVIID) is the most common of inherited rare bleeding disorders. Other determinants of clinical severity apart from FVII level (FVIIL) include genetic and environmental factors. We aimed to identif